JAMIE GRIFFITH: Open Payments
NPI 1083968838 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,106 in 134 payments from 16 companies in 2025. Trend: 2023 $2,392 · 2024 $2,113 · 2025 $2,106
Food & beverage: $2,106
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 18 | $403 |
| Janssen Biotech, Inc. | 19 | $390 |
| Galderma Laboratories, L.P. | 15 | $226 |
| Amgen Inc. | 14 | $214 |
| Organon LLC | 17 | $186 |
| Botanix SB Inc | 25 | $155 |
| Novartis Pharmaceuticals Corporation | 4 | $92 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $92 |
| Lilly USA, LLC | 4 | $76 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $70 |
Products named: Bimzelx, TREMFYA, OTEZLA, SOFDRA, NEMLUVIO, VTAMA, AKLIEF, COSENTYX.
Industry payments across MO — which companies pay providers there.
